| Source | Code | Name | Case count | Share of cases (%) |
|---|---|---|---|---|
| PURCH | PURCH_ATC(L04AB04) | Adalimumab | 3130 | |
| PURCH | PURCH_ATC(L04AB01) | Etanercept | 2244 | |
| PURCH | PURCH_ATC(L04AB06) | Golimumab | 1120 | |
| PURCH | PURCH_ATC(L04AB05) | Certolizumab pegol | 567 | |
| PURCH | PURCH_ATC(L04AC10) | Secukinumab | 515 | |
| PURCH | PURCH_ATC(L04AC05) | Ustekinumab | 482 | |
| PURCH | PURCH_ATC(L04AA24) | Abatacept | 467 | |
| PURCH | PURCH_ATC(L04AC07) | Tocilizumab | 324 | |
| PURCH | PURCH_ATC(L04AC03) | Anakinra | 41 | |
| PURCH | PURCH_ATC(L04AB02) | Infliximab | 21 |